dc.creator | Valotassiou V., Angelidis G., Psimadas D., Tsougos I., Georgoulias P. | en |
dc.date.accessioned | 2023-01-31T10:25:06Z | |
dc.date.available | 2023-01-31T10:25:06Z | |
dc.date.issued | 2020 | |
dc.identifier | 10.1007/s00259-020-05077-2 | |
dc.identifier.issn | 16197070 | |
dc.identifier.uri | http://hdl.handle.net/11615/80361 | |
dc.description.abstract | [No abstract available] | en |
dc.language.iso | en | en |
dc.source | European Journal of Nuclear Medicine and Molecular Imaging | en |
dc.source.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85092787202&doi=10.1007%2fs00259-020-05077-2&partnerID=40&md5=89849f4680504c507f17844c89c7d23f | |
dc.subject | biological marker | en |
dc.subject | fluorodeoxyglucose f 18 | en |
dc.subject | Alzheimer disease | en |
dc.subject | brain | en |
dc.subject | diagnostic imaging | en |
dc.subject | human | en |
dc.subject | perfusion | en |
dc.subject | positron emission tomography | en |
dc.subject | single photon emission computed tomography | en |
dc.subject | Alzheimer Disease | en |
dc.subject | Biomarkers | en |
dc.subject | Brain | en |
dc.subject | Fluorodeoxyglucose F18 | en |
dc.subject | Humans | en |
dc.subject | Perfusion | en |
dc.subject | Positron-Emission Tomography | en |
dc.subject | Tomography, Emission-Computed, Single-Photon | en |
dc.subject | Springer Science and Business Media Deutschland GmbH | en |
dc.title | In the era of FDG PET, is it time for brain perfusion SPECT to gain a place in Alzheimer’s disease imaging biomarkers? | en |
dc.type | other | en |